110 related articles for article (PubMed ID: 21967854)
1. Preliminary evidence that acute long-chain omega-3 supplementation reduces cardiovascular reactivity to mental stress: a randomized and placebo controlled trial.
Ginty AT; Conklin SM
Biol Psychol; 2012 Jan; 89(1):269-72. PubMed ID: 21967854
[TBL] [Abstract][Full Text] [Related]
2. Effect of omega-3 fatty acid-containing phospholipids on blood catecholamine concentrations in healthy volunteers: a randomized, placebo-controlled, double-blind trial.
Hamazaki K; Itomura M; Huan M; Nishizawa H; Sawazaki S; Tanouchi M; Watanabe S; Hamazaki T; Terasawa K; Yazawa K
Nutrition; 2005 Jun; 21(6):705-10. PubMed ID: 15925295
[TBL] [Abstract][Full Text] [Related]
3. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder.
Young GS; Conquer JA; Thomas R
Reprod Nutr Dev; 2005; 45(5):549-58. PubMed ID: 16188207
[TBL] [Abstract][Full Text] [Related]
4. The effects of 90-day supplementation with the omega-3 essential fatty acid docosahexaenoic acid (DHA) on cognitive function and visual acuity in a healthy aging population.
Stough C; Downey L; Silber B; Lloyd J; Kure C; Wesnes K; Camfield D
Neurobiol Aging; 2012 Apr; 33(4):824.e1-3. PubMed ID: 21531481
[TBL] [Abstract][Full Text] [Related]
5. Delayed omega-3 fatty acid supplements in renal transplantation. A double-blind, placebo-controlled study.
Bennett WM; Carpenter CB; Shapiro ME; Strom TB; Hefty D; Tillman M; Abrams J; Ryan D; Kelley VR
Transplantation; 1995 Feb; 59(3):352-6. PubMed ID: 7871564
[TBL] [Abstract][Full Text] [Related]
6. Omega-3 fatty acid supplementation in patients with chronic epilepsy: a randomized trial.
Yuen AW; Sander JW; Fluegel D; Patsalos PN; Bell GS; Johnson T; Koepp MJ
Epilepsy Behav; 2005 Sep; 7(2):253-8. PubMed ID: 16006194
[TBL] [Abstract][Full Text] [Related]
7. The omega-3 fatty acids EPA and DHA decrease plasma F(2)-isoprostanes: Results from two placebo-controlled interventions.
Mas E; Woodman RJ; Burke V; Puddey IB; Beilin LJ; Durand T; Mori TA
Free Radic Res; 2010 Sep; 44(9):983-90. PubMed ID: 20540666
[TBL] [Abstract][Full Text] [Related]
8. Effect of omega-3 polyunsaturated fatty acid supplementation on semen profile and enzymatic anti-oxidant capacity of seminal plasma in infertile men with idiopathic oligoasthenoteratospermia: a double-blind, placebo-controlled, randomised study.
Safarinejad MR
Andrologia; 2011 Feb; 43(1):38-47. PubMed ID: 21219381
[TBL] [Abstract][Full Text] [Related]
9. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.
Freund-Levi Y; Eriksdotter-Jönhagen M; Cederholm T; Basun H; Faxén-Irving G; Garlind A; Vedin I; Vessby B; Wahlund LO; Palmblad J
Arch Neurol; 2006 Oct; 63(10):1402-8. PubMed ID: 17030655
[TBL] [Abstract][Full Text] [Related]
10. Risk stratification by the "EPA+DHA level" and the "EPA/AA ratio" focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids.
Rupp H; Wagner D; Rupp T; Schulte LM; Maisch B
Herz; 2004 Nov; 29(7):673-85. PubMed ID: 15580322
[TBL] [Abstract][Full Text] [Related]
11. Impact of foods enriched with n-3 long-chain polyunsaturated fatty acids on erythrocyte n-3 levels and cardiovascular risk factors.
Murphy KJ; Meyer BJ; Mori TA; Burke V; Mansour J; Patch CS; Tapsell LC; Noakes M; Clifton PA; Barden A; Puddey IB; Beilin LJ; Howe PR
Br J Nutr; 2007 Apr; 97(4):749-57. PubMed ID: 17349088
[TBL] [Abstract][Full Text] [Related]
12. Effects of trans- and n-3 unsaturated fatty acids on cardiovascular risk markers in healthy males. An 8 weeks dietary intervention study.
Dyerberg J; Eskesen DC; Andersen PW; Astrup A; Buemann B; Christensen JH; Clausen P; Rasmussen BF; Schmidt EB; Tholstrup T; Toft E; Toubro S; Stender S
Eur J Clin Nutr; 2004 Jul; 58(7):1062-70. PubMed ID: 15220949
[TBL] [Abstract][Full Text] [Related]
13. Omega-3 fatty acid supplementation effects on weight and appetite in patients with Alzheimer's disease: the omega-3 Alzheimer's disease study.
Irving GF; Freund-Levi Y; Eriksdotter-Jönhagen M; Basun H; Brismar K; Hjorth E; Palmblad J; Vessby B; Vedin I; Wahlund LO; Cederholm T
J Am Geriatr Soc; 2009 Jan; 57(1):11-7. PubMed ID: 19054188
[TBL] [Abstract][Full Text] [Related]
14. A multicentre, double-masked, randomized, controlled trial assessing the effect of oral supplementation of omega-3 and omega-6 fatty acids on a conjunctival inflammatory marker in dry eye patients.
Brignole-Baudouin F; Baudouin C; Aragona P; Rolando M; Labetoulle M; Pisella PJ; Barabino S; Siou-Mermet R; Creuzot-Garcher C
Acta Ophthalmol; 2011 Nov; 89(7):e591-7. PubMed ID: 21834921
[TBL] [Abstract][Full Text] [Related]
15. Background and rationale of the SU.FOL.OM3 study: double-blind randomized placebo-controlled secondary prevention trial to test the impact of supplementation with folate, vitamin B6 and B12 and/or omega-3 fatty acids on the prevention of recurrent ischemic events in subjects with atherosclerosis in the coronary or cerebral arteries.
Galan P; de Bree A; Mennen L; Potier de Courcy G; Preziozi P; Bertrais S; Castetbon K; Hercberg S
J Nutr Health Aging; 2003; 7(6):428-35. PubMed ID: 14625623
[TBL] [Abstract][Full Text] [Related]
16. The content of docosahexaenoic acid in serum phospholipid is inversely correlated with plasma homocysteine levels in patients with end-stage renal disease.
Rasmussen LE; Svensson M; Jørgensen KA; Schmidt EB; Christensen JH
Nutr Res; 2010 Aug; 30(8):535-40. PubMed ID: 20851307
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular disease prevention and treatment.
von Schacky C
Prostaglandins Leukot Essent Fatty Acids; 2009; 81(2-3):193-8. PubMed ID: 19520557
[TBL] [Abstract][Full Text] [Related]
18. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.
Amminger GP; Schäfer MR; Papageorgiou K; Klier CM; Cotton SM; Harrigan SM; Mackinnon A; McGorry PD; Berger GE
Arch Gen Psychiatry; 2010 Feb; 67(2):146-54. PubMed ID: 20124114
[TBL] [Abstract][Full Text] [Related]
19. Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial.
Dunstan JA; Simmer K; Dixon G; Prescott SL
Arch Dis Child Fetal Neonatal Ed; 2008 Jan; 93(1):F45-50. PubMed ID: 17185423
[TBL] [Abstract][Full Text] [Related]
20. Differential immunomodulation with long-chain n-3 PUFA in health and chronic disease.
Sijben JW; Calder PC
Proc Nutr Soc; 2007 May; 66(2):237-59. PubMed ID: 17466105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
